Pipobroman
CAS: 54-91-1
Ref. 3D-FP177387
1g | A consultar | ||
2g | A consultar | ||
100mg | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Información del producto
- 1,1′-(1,4-Piperazinediyl)bis[3-bromo-1-propanone]
- 1,1′-(Piperazine-1,4-diyl)bis(3-bromopropan-1-one)
- 1,4-Bis(3-bromopropionyl)piperazine
- 1,4-Di(3-bromopropionyl)piperazine
- 1-Propanone, 1,1'-(1,4-piperazinediyl)bis[3-bromo-
- 3-Bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one
- A 1803
- Amedel
- N,N'-Bis(3-bromopropionyl)piperazine
- Nsc-25154
- Ver más sinónimos
- Piperazine, 1,4-bis(3-bromopropionyl)-
- Vercyte
Pipobroman is an anti-cancer compound that belongs to the group of cytotoxic drugs. It is used in the treatment of solid tumours, and has shown a therapeutic effect on skin cancer when combined with other agents. Pipobroman binds to DNA and inhibits DNA synthesis. The drug also has been shown to inhibit the expression of Jak2 V617F, which is a mutation that is associated with hematologic response. Pipobroman has been shown to be effective against polycythaemia in mice and rats, as well as against erythrocytosis in dogs. Overall, pipobroman appears to be safe for use in humans but should not be administered for long periods of time due to its potential toxic effects on the liver and kidneys.
Propiedades químicas
Consulta técnica sobre: 3D-FP177387 Pipobroman
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.